Search Results - "Hamid, Arsalan"

Refine Results
  1. 1
  2. 2
  3. 3

    Two Cases of Highly Symptomatic Interarterial Anomalous Right Coronary Arteries by Clay, Kyle J, Hamid, Arsalan, Deere, Bradley P

    Published in Curēus (Palo Alto, CA) (31-07-2023)
    “…Coronary artery anomalies are a broad group of congenital coronary artery variations. Anomalous aortic origin of a coronary artery is a variant that occurs…”
    Get full text
    Journal Article
  4. 4

    How do breast cancer clinical trials approach cardiovascular safety: targeted or generalized? by Hamid, Arsalan, Fonarow, Gregg C, Butler, Javed, Hall, Michael E

    Published in Cardio-oncology (London, England) (07-02-2024)
    “…Different breast cancer pharmacotherapy agents cause different forms of cardiovascular toxicity. We aim to assess if breast cancer pharmacotherapy trials…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cardiovascular Safety Reporting in Contemporary Breast Cancer Clinical Trials by Hamid, Arsalan, Anker, Markus S., Ruckdeschel, John C., Khan, Muhammad Shahzeb, Tharwani, Arsal, Oshunbade, Adebamike A., Kipchumba, Rodney K., Thigpen, Samuel C., Anker, Stefan D., Fonarow, Gregg C., Hall, Michael E., Butler, Javed

    Published in Journal of the American Heart Association (02-08-2022)
    “…Background Several cancer therapies have been associated with cardiovascular harm in early‐phase clinical trials. However, some cardiovascular harms do not…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Multivessel Percutaneous Coronary Intervention in a Patient With Bernard-Soulier Syndrome by Faheem, Osman, Hussain, Bilal, Khurshid, Mohammad, Hamid, Arsalan, Rashid, Anila

    Published in JACC. Case reports (01-04-2020)
    “…Bernard-Soulier syndrome, a congenital bleeding disorder, can rarely present with atherosclerosis and thrombosis. Acute coronary syndrome in such patients…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Abstract 14765: Cardiovascular Safety Reporting Among Cancer Pharmacotherapy Agents in Breast Cancer Clinical Trials by Hamid, Arsalan, Thigpen, Samuel C, Butler, Javed, Hall, Michael E

    Published in Circulation (New York, N.Y.) (08-11-2022)
    “…IntroductionCancer pharmacotherapy has been associated with cardiovascular (CV) harm in early phase trials. Later phase (2 & 3) trials offer potential to…”
    Get full text
    Journal Article
  12. 12

    Abstract 17986: Impact of Race and Socioeconomic Factors on Hypertensive Emergency by Rizwan, Affan M, Mace, Hunter, Hamid, Arsalan, Clark, Donald, Hall, Michael

    Published in Circulation (New York, N.Y.) (07-11-2023)
    “…Abstract only Background: Hypertensive emergency, defined as a blood pressure ≥ 180/110mmHg with target organ damage, is a major cause of cardiovascular…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Abstract 12856: Electrocardiographic T Wave Inversion and Cardiac Structure and Function by Kamimura, Daisuke, Yimer, Wondwosen, Mentz, Robert J, Butler, Javed, Shah, Amil M, Akbilgic, Oguz, Kheirkhahan, Mobin, Tio, Maria Clarissa, Hamid, Arsalan, Suzuki, Takeki, Hall, Michael E

    Published in Circulation (New York, N.Y.) (07-11-2023)
    “…Abstract only Background: Electrocardiographic T wave inversion (TWI) has been associated with incident heart failure (HF) in Black Americans without known…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Estimated Glomerular Filtration Rate Slope as an Endpoint in Cardiovascular Trials by Hamid, Arsalan, Greene, Stephen J, Mehta, Ankit, Butler, Javed, Khan, Muhammad Shahzeb

    Published in Current heart failure reports (01-08-2024)
    “…Purpose of Review End stage kidney disease can be a slow process and it may be challenging to achieve required follow-up for sufficient events. Therefore, a…”
    Get full text
    Journal Article